Sannovex Pharmaceuticalsfield Force Started In 2010 With The Arrival Of Sannovex Branded Products From Global Manufacturers In Chinaindia And Later In Europe In 2011It Started With Ten10Medical Representativesincreased To Twenty Five25In 2011Forty40In 2012And Eighty80In The Fourth Quarter Of 2013 Under Two Divisionsline 1 And Line 2 Sannovex Pharmaceuticals Markets Products In Injection Forms But Has Started In 2013 Negotiations For Licensing & Manufacturing Agreement For Oral Preparations & Expanding Preparations For Injections With European Manufacturers For Its Cardio Metabolic Divisionanti Infectivesgastro Intestinaloncologycnsanti Allergyanalgesicanti Inflammatory Products & Non Ethical Preparations During The Cphi Frankfurtgermany Convention The Marketing Of Sannovex Branded Products Is Limited To Molecules That Are Already Off Patent And Those Classified As Highly Essential Drugs In The Philippine National Drug Formulary That Bridges The Gap Between Efficacy And Affordability Of High Quality Medicinessannovex Target Clients Are Basically Private And Government Major And Minor Hospitals With Good Credit Standing
